Alivus Life Sciences Limited

Direct answer

Alivus Life Sciences Limited is publicly traded on BSE under the ticker ALIVUS.BO.

Alivus Life Sciences Limited develops, manufactures, and markets active pharmaceutical ingredients in India, Japan, Europe, North and Latin America, and internationally. It offers various APIs, such as olmesartan, telmisartan, solifenacin, sitagliptin, zonisamide, rosuvastatin, amiodarone, ezetimibe, lithium carbonate, oxcarbazepine, mirabegron, atovaquone, etoricoxib, remogliflozin, cabozantinib, and palbociclib...

Can you invest in Alivus Life Sciences Limited?

Yes. Alivus Life Sciences Limited trades publicly on BSE as ALIVUS.BO.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Alivus Life Sciences Limited

Detailed equity research is provided by MarketSnap.